The pso Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the pso Hub cannot guarantee the accuracy of translated content. The pso and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB: For educational content and news updates.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View pso content recommended for you
Barbra BohannanDuring The European Congress of Rheumatology (EULAR) 2023, the Psoriasis and Psoriatic Arthritis Hub was pleased to speak with Barbra Bohannan, Swedish Psoriasis Association, Stockholm, SE. We asked about insights on living with psoriatic disease.
Living with psoriatic disease
Bohannan discusses the challenges she has faced while dealing with psoriatic arthritis, including comorbidities, stress, and environmental factors. She goes on to discuss the importance of considering the factors influencing treatment outcomes, such as age, gender, and disease severity. Finally, Bohannan discusses the most effective ways to approach difficult topics with patients, and describes how communication is imperative for a better understanding of disease progression and ultimately, improved treatment outcomes.
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content